Researchers in Organizations with Fewer Than 500 Employees Can Enjoy Immediate Subscription Access to Peer-Reviewed Journals Within CCC’s Award-Winning Content Workflow Solution

August 9, 2022 – Danvers, Mass. CCC, a leader in advancing copyright, accelerating knowledge, and powering innovation, is now offering subscriptions to select publishers including the JAMA Network and the New England Journal of Medicine (NEJM) through CCC’s advanced content workflow solution, RightFind, to meet the needs of researchers in organizations with fewer than 500 employees.

Originating as a pilot program with Wiley, the Publisher Subscriptions through RightFind service lets these organizations switch from on-demand individual article purchases to enterprise subscriptions for prominent journals.

RightFind provides immediate access to subscribed scientific, technical, and medical (STM) content. It also has the functionality to easily purchase unsubscribed content as well as tools for collaborating in a copyright-compliant way directly in the RightFind workflow.

“Publisher Subscriptions through RightFind provide access to all articles from these high-impact journals at a set annual price, giving researchers immediate access to the latest research without interruption,” said Lauren Tulloch, Vice President and Managing Director, Corporate Solutions, CCC. “Researchers get the convenience of staying in the RightFind workflow while publishers benefit from another channel for renewable subscription sales.”

“At the JAMA Network, we are interested in providing our readers the most seamless access to the research, opinion, and clinical educational content we publish,” said Vida Damijonaitis, JAMA Network Director of Worldwide Sales. “This partnership with CCC’s RightFind will help us expand our reach and make it easier for our global audience to discover our content.”

“NEJM is pleased to participate in an innovative new service from CCC that aligns with our goal to meet the information needs of researchers for the highest quality studies in medical science,” said Rob McKinney, Director, NEJM Group Licensing.

CCC’s award-winning RightFind research solution is used by hundreds of global R&D teams and other corporate content users from the smallest emerging life sciences companies to the largest global R&D organizations. The RightFind solution helps companies with their copyright compliance by integrating seamlessly with CCC’s annual copyright licenses. It provides centralized, seamless access to high-value content from subscriptions and licenses while offering on-demand document delivery.  

The JAMA Network brings JAMA together with JAMA Network Open and 11 specialty medical journals to offer enhanced access to the research, reviews, and opinions shaping the future of medicine. The JAMA Network is part of the AMA, the premier national organization dedicated to empowering the nation’s physicians to provide safer, higher-quality care for patients and communities.

NEJM is recognized as the world’s leading medical journal and website. Published continuously for over 200 years, NEJM delivers high-quality, peer-reviewed research and interactive clinical content to physicians, educators, researchers, and the global medical community.

About CCC

A pioneer in voluntary collective licensing, CCC is a leading information solutions provider to organizations around the world. With deep domain expertise in copyright, technology, content, PIDs, FAIR data principles, metadata, and more, CCC works to advance copyright, accelerate knowledge, and power innovation. CCC and its subsidiary RightsDirect help organizations harness the power of data, AI, and machine learning to drive strategic decision-making, grow their businesses, and gain competitive advantage.